IPSC Insider Trading Activity and SEC Form 4 Filings
IPSC insider trading summary
Over the past 12 months, insiders at Century Therapeutics, Inc. (IPSC) reported 18 sales worth $85K by 4 insiders and 2 open-market purchases worth $48K by 1 insider on SEC Form 4. Net insider selling was $37K.
Latest IPSC insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 3, 2026 | Douglas Carr | SVP Finance & Operations | Sell | $404 (266 @ $1.52) |
| Sep 14, 2026 | Gregory Russotti | See Remarks | Sell | $5K (2,587 @ $1.93) |
| Sep 14, 2026 | Douglas Carr | SVP Finance & Operations | Sell | $3K (1,658 @ $1.93) |
| Aug 3, 2026 | Douglas Carr | SVP Finance & Operations | Sell | $544 (275 @ $1.98) |
| Jun 12, 2026 | Douglas Carr | SVP Finance & Operations | Sell | $4K (1,654 @ $2.23) |
| Jun 12, 2026 | Gregory Russotti | See Remarks | Sell | $6K (2,584 @ $2.23) |
| Jun 8, 2026 | Douglas Carr | SVP Finance & Operations | Sell | $526 (249 @ $2.11) |
| Jun 8, 2026 | Gregory Russotti | See Remarks | Sell | $1K (524 @ $2.11) |
| May 4, 2026 | Douglas Carr | SVP Finance & Operations | Sell | $618 (264 @ $2.34) |
| Mar 12, 2026 | Gregory Russotti | See Remarks | Sell | $26K (10,076 @ $2.55) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.